Pharmaceuticals news FT.com

Pfizer CEO ‘disappointed’ by Kennedy’s refusal to rebut claims on jab risks

Albert Bourla says Donald Trump’s nominee for health secretary still appeared to ‘temper’ some of his views

Feb 9, 2025 - 21:46
 0
Pfizer CEO ‘disappointed’ by Kennedy’s refusal to rebut claims on jab risks
Albert Bourla says Donald Trump’s nominee for health secretary still appeared to ‘temper’ some of his views
Read More

Tags:

Previous Article

GSK launches £2bn buyback on strong HIV and cancer drugs sales

Next Article

Merck shares sink 11% after vaccine shipments to China halted

Related Posts

AstraZeneca sales jump despite troubles in China

AstraZeneca sales jump despite troubles in China

Feb 9, 2025  0

‘Quick and easy’ blood tests for ageing organs detect disease risks

‘Quick and easy’ blood tests for ageing organs detect d...

Feb 26, 2025  0

Eli Lilly unveils $27bn US investment as corporate America seeks to woo Trump

Eli Lilly unveils $27bn US investment as corporate Amer...

Feb 26, 2025  0